The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2021 3
2020 1

United States 3

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018

CITE Title : Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018 Personal Author(s) : Wesley, Meredith G.;Soto, Giselle;Arriola, Carmen Sofia;Gonzales, Miriam;Newes‐Adeyi, Gabriella;Romero, Candice;Veguilla, Vic;Levine, Min Z.;Silva, Maria;Ferdinands, Jill M.;Dawood, Fatimah S.;Reynolds, Sue B.;Hirsch, Avital;Katz, Mark;Matos, Eduardo;Ticona, Eduardo;Castro, Juan;Castillo, Maria;Bravo, Eduar;Cheung, Angela;Phadnis, Rachel;Martin, Emily Toth;Tinoco, Yeny;Neyra Quijandria, Joan Manuel;Azziz‐Baumgartner, Eduardo;Thompson, Mark G.; Corporate Authors(s) : VIP Cohort Study Working Group Published Date : April 05 2020;7-2020; Source : Influenza Other Respir Viruses. 14(4):391-402 URL : https://stacks.cdc.gov/view/cdc/91076 Wesley, Meredith G. et al. (2020). Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018. 14(4). Wesley, Meredith G. et al. "Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018" 14, no. 4 (2020) Wesley, Meredith G. et al. "Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018" vol. 14, no. 4, 2020 Export RIS Citation Information.

:

Wesley, Meredith G. ;

Soto, Giselle

April 05 2020 | Influenza Other Respir Viruses. 14(4):391-402

:

BackgroundThe Estudio Vacuna de Influenza Peru (VIP) cohort aims to describe the frequency of influenza virus infection, identify predictors of vaccin...
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers

CITE Title : Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers Personal Author(s) : Ellingson, Katherine D.;Hollister, James;Porter, Cynthia J.;Khan, Sana M.;Feldstein, Leora R.;Naleway, Allison L.;Gaglani, Manjusha;Caban-Martinez, Alberto J.;Tyner, Harmony L.;Lowe, Ashley A.;Olsho, Lauren E.W.;Meece, Jennifer;Yoon, Sarang K.;Mak, Josephine;Kuntz, Jennifer L.;Solle, Natasha Schaefer;Respet, Karley;Baccam, Zoe;Wesley, Meredith G.;Thiese, Matthew S.;Yoo, Young M.;Odean, Marilyn J.;Miiro, Flavia N.;Pickett, Steve L.;Phillips, Andrew L.;Grant, Lauren;Romine, James K.;Herring, Meghan K.;Hegmann, Kurt T.;Lamberte, Julie Mayo;Sokol, Brian;Jovel, Krystal S.;Thompson, Mark G.;Rivers, Patrick;Pilishvili, Tamara;Lutrick, Karen;Burgess, Jefferey L.;Midgley, Claire M.;Fowlkes, Ashley L.; Published Date : 3 2023 Source : Emerg Infect Dis. 2023; 29(3):599-604 URL : https://stacks.cdc.gov/view/cdc/127659 Ellingson, Katherine D. et al. (2023). Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers. 29(3). Ellingson, Katherine D. et al. "Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers" 29, no. 3 (2023) Ellingson, Katherine D. et al. "Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers" vol. 29, no. 3, 2023 Export RIS Citation Information.

:

Ellingson, Katherine D. ;

Hollister, James

3 2023 | Emerg Infect Dis. 2023; 29(3):599-604

:

In a cohort of essential workers in the United States previously infected with SARS-CoV-2, risk factors for reinfection included being unvaccinated, i...
Performance of Symptom-Based Case Definitions to Identify Influenza Virus Infection Among Pregnant Women in Middle-Income Countries: Findings From the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study

CITE Title : Performance of Symptom-Based Case Definitions to Identify Influenza Virus Infection Among Pregnant Women in Middle-Income Countries: Findings From the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study Personal Author(s) : Wesley, Meredith G.;Tinoco, Yeny;Patel, Archana;Suntarratiwong, Piyarat;Hunt, Danielle;Sinthuwattanawibool, Chalinthorn;Soto, Giselle;Kittikraisak, Wanitchaya;Das, Prabir Kumar;Arriola, Carmen Sofia;Hombroek, Danielle;Mott, Joshua;Kurhe, Kunal;Bhargav, Savita;Prakash, Amber;Florian, Richard;Gonzales, Oswaldo;Cabrera, Santiago;Llajaruna, Edwin;Brummer, Tana;Malek, Parker;Saha, Siddhartha;Garg, Shikha;Azziz-Baumgartner, Eduardo;Thompson, Mark G.;Dawood, Fatimah S.; Published Date : 12 06 2021;12-06-; Source : Clin Infect Dis. 73(11):e4321-e4328 URL : https://stacks.cdc.gov/view/cdc/134132 Wesley, Meredith G. et al. (2021). Performance of Symptom-Based Case Definitions to Identify Influenza Virus Infection Among Pregnant Women in Middle-Income Countries: Findings From the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study. 73(11). Wesley, Meredith G. et al. "Performance of Symptom-Based Case Definitions to Identify Influenza Virus Infection Among Pregnant Women in Middle-Income Countries: Findings From the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study" 73, no. 11 (2021) Wesley, Meredith G. et al. "Performance of Symptom-Based Case Definitions to Identify Influenza Virus Infection Among Pregnant Women in Middle-Income Countries: Findings From the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study" vol. 73, no. 11, 2021 Export RIS Citation Information.

:

Wesley, Meredith G.

;

Tinoco, Yeny

12 06 2021 | Clin Infect Dis. 73(11):e4321-e4328

:

Background.The World Health Organization (WHO) recommends case definitions for influenza surveillance that are also used in public health research, al...
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

CITE Title : Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 Personal Author(s) : Thompson, Mark G.;Burgess, Jefferey L.;Naleway, Allison L.;Tyner, Harmony L.;Yoon, Sarang K.;Meece, Jennifer;Olsho, Lauren E.W.;Caban-Martinez, Alberto J.;Fowlkes, Ashley;Lutrick, Karen;Kuntz, Jennifer L.;Dunnigan, Kayan;Odean, Marilyn J.;Hegmann, Kurt T.;Stefanski, Elisha;Edwards, Laura J.;Schaefer-Solle, Natasha;Grant, Lauren;Ellingson, Katherine;Groom, Holly C.;Zunie, Tnelda;Thiese, Matthew S.;Ivacic, Lynn;Wesley, Meredith G.;Lamberte, Julie Mayo;Sun, Xiaoxiao;Smith, Michael E.;Phillips, Andrew L.;Groover, Kimberly D.;Yoo, Young M.;Gerald, Joe;Brown, Rachel T.;Herring, Meghan K.;Joseph, Gregory;Beitel, Shawn;Morrill, Tyler C.;Mak, Josephine;Rivers, Patrick;Harris, Katherine M.;Hunt, Danielle R.;Arvay, Melissa L.;Kutty, Preeta;Fry, Alicia M.;Gaglani, Manjusha; Published Date : April 02 2021 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 70(13):495-500 URL : https://stacks.cdc.gov/view/cdc/105169 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Thompson, Mark G. et al. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021. 70(13). Thompson, Mark G. et al. "Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021" 70, no. 13 (2021) Thompson, Mark G. et al. "Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021" vol. 70, no. 13, 2021 Export RIS Citation Information.

:

Thompson, Mark G. ;

Burgess, Jefferey L.

April 02 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines have been shown to be effective in preventing symptomatic CO...
Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

CITE Title : Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 Personal Author(s) : Thompson, Mark G.;Burgess, Jefferey L.;Naleway, Allison L.;Tyner, Harmony L.;Yoon, Sarang K.;Meece, Jennifer;Olsho, Lauren E. W.;Caban-Martinez, Alberto J.;Fowlkes, Ashley;Lutrick, Karen;Kuntz, Jennifer L.;Dunnigan, Kayan;Odean, Marilyn J.;Hegmann, Kurt T.;Stefanski, Elisha;Edwards, Laura J.;Schaefer-Solle, Natasha;Grant, Lauren;Ellingson, Katherine;Groom, Holly C.;Zunie, Tnelda;Thiese, Matthew S.;Ivacic, Lynn;Wesley, Meredith G.;Lamberte, Julie Mayo;Sun, Xiaoxiao;Smith, Michael E.;Phillips, Andrew L.;Groover, Kimberly D.;Yoo, Young M.;Gerald, Joe;Brown, Rachel T.;Herring, Meghan K.;Joseph, Gregory;Beitel, Shawn;Morrill, Tyler C.;Mak, Josephine;Rivers, Patrick;Harris, Katherine M.;Hunt, Danielle R.;Arvay, Melissa L.;Kutty, Preeta;Fry, Alicia M.;Gaglani, Manjusha; Corporate Authors(s) : CDC COVID-19 Response Team.;University of Arizona. College of Public Health.;Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region);St. Luke’s (Duluth, Minnesota);University of Utah.;Marshfield Clinic. Research Laboratory.;Abt Associates.;Leonard M. Miller School of Medicine.;Baylor Scott & White Health.;Whiteside Institute for Clinical Research.;Texas A&M University. College of Medicine.; Published Date : March 29, 2021 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/104585 Thompson, Mark G. et al. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021. 70 Thompson, Mark G. et al. "Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021" 70 (2021) Thompson, Mark G. et al. "Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021" vol. 70, 2021 Export RIS Citation Information.

:

Thompson, Mark G. ;

Burgess, Jefferey L.

March 29, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Messenger RNA (mRNA) COVID-19 vaccines have been shown to be effective in preventing symptomatic SARS-CoV-2 in...